BODIPY 581/591 C11: Ratiometric Probe for Lipid Peroxidation
2026-06-25
BODIPY 581/591 C11 stands out as a ratiometric fluorescent probe, providing robust, quantitative lipid peroxidation detection in live cells and membrane models. Its red-to-green emission shift enables precise oxidative stress measurement and empowers workflows for antioxidant capacity evaluation in complex biological systems.
RCN2 Drives ESCC Metastasis and Cisplatin Resistance via PI3
2026-06-24
This study identifies RCN2 as a key mediator of metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) through UBR5-dependent degradation of PPP2CA, resulting in PI3K-Akt pathway activation. The findings offer mechanistic insights for targeting therapy-resistant ESCC.
Stable Five-Element Nanoparticles for Lung-Specific mRNA Del
2026-06-23
This study introduces five-element nanoparticles (FNPs) designed for highly stable, lung-targeted mRNA delivery. By optimizing polymer components and employing lyophilization, the FNPs demonstrate prolonged storage at 4°C, addressing key barriers to widespread mRNA therapeutic deployment.
Tunable Human Intestinal Organoids: Balancing Self-Renewal a
2026-06-23
This study introduces a human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule pathway modulators. The optimized approach enhances cellular diversity and proliferative capacity in vitro, advancing the scalability and utility of organoid models for disease and developmental research.
Cy7 NHS Ester: Near-Infrared Dye for Protein Labeling (A8109
2026-06-22
Sulfo-Cy7 NHS Ester (A8109) addresses the need for hydrophilic, low-quenching near-infrared fluorescent labeling of proteins and peptides, especially in live cell and tissue imaging workflows. It is not suitable for applications requiring long-term storage of conjugated solutions or for labeling targets lacking accessible amino groups.
Fucoidan’s Novel Role in Caveolin-1 Modulation and Breast Ca
2026-06-22
Explore how Fucoidan, a sulfated α-L-fucan, uniquely regulates caveolin-1 in breast cancer cells, revealing new therapeutic strategies. This in-depth article connects advanced mechanistic insights to practical laboratory workflows and highlights what sets APExBIO’s Fucoidan apart.
ABT-737: Redefining BCL-2 Protein Inhibition in Cancer Model
2026-06-21
Explore how ABT-737, a potent BCL-2 protein inhibitor, advances cancer research by enabling precise mitochondrial apoptosis induction. This article offers a unique, evidence-based analysis of its mechanistic selectivity and practical assay implications, surpassing existing guides.
Ibuprofen in Cancer Research: Mechanistic Insights and Assay
2026-06-20
Explore how Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) drives innovation in colon cancer research, apoptosis induction, and cell cycle arrest assays. This article offers advanced, evidence-based guidance distinct from standard protocols.
Glycogen Colorimetric Assay Kit II: Precision Glycogen Quant
2026-06-19
The Glycogen Colorimetric Assay Kit II enables high-sensitivity, interference-resistant quantification of tissue glycogen. This product supports reproducible results in metabolic and circadian research, as validated in recent endurance and glycogen adaptation studies.
Tetramethylrhodamine Ethyl Ester Perchlorate for Mitochondri
2026-06-19
Tetramethylrhodamine ethyl ester perchlorate is a membrane-permeable rhodamine-like fluorescent dye enabling live-cell mitochondrial membrane potential assays with high sensitivity and low cytotoxicity. It accumulates selectively in active mitochondria, providing quantitative metrics for mitochondrial health. Used in various fluorescence-based workflows, it is central to mitochondrial dysfunction research and apoptosis studies.
Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid): Mech
2026-06-18
Ibuprofen is a dual COX-1/COX-2 inhibitor with anti-inflammatory and anti-proliferative properties. It demonstrates apoptosis induction and cell cycle arrest in colon carcinoma cells, with distinct solubility and storage guidelines essential for experimental reproducibility. This article details its molecular action, validated applications, and practical constraints for oncology research.
Comprehensive Protease Inhibition in Plant Extracts: Innovat
2026-06-18
Explore the advanced mechanisms and assay implications of the Protease Inhibitor Cocktail for plant cell protein stability. This article reveals new insights into protein degradation inhibition, tying cutting-edge plant immunity research to practical laboratory workflows.
Metoprolol as a Selective Beta1-Adrenoceptor Antagonist in R
2026-06-17
Metoprolol stands out as a selective beta1-adrenoceptor antagonist, empowering advanced cardiovascular, anti-inflammatory, and tumor biology research. This guide translates bench-to-publication workflows and troubleshooting tips, leveraging APExBIO’s high-purity Metoprolol and state-of-the-art PK insights for rigorous, reproducible results.
SFRP1 Modulation of Wnt/β-Catenin Pathway in Oral Submucous
2026-06-17
This study reveals that SFRP1 alleviates oral submucous fibrosis (OSF) by reducing neutrophil infiltration and inhibiting the Wnt/β-catenin pathway in a mouse model. These findings clarify the interplay between immunomodulation and fibrotic signaling in OSF and suggest new directions for targeting the Wnt/β-catenin pathway in fibrotic disease research.
Phenacetin as a Translational Benchmark in Organoid PK Studi
2026-06-16
Explore how Phenacetin (N-(4-ethoxyphenyl)acetamide), a legacy analgesic, is reshaping translational pharmacokinetic research in advanced human organoid models. This article bridges mechanistic insight and strategic implementation, guiding researchers to leverage Phenacetin’s unique profile for high-fidelity absorption and metabolism studies, while contextualizing its limitations and opportunities in precision medicine.
459 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page